All Stories

  1. Investigating the Mechanisms Underlying Cell Death Induction by a Tributyltin Molecule in HTLV-1-Infected Cells Dependent or Not on IL-2 as a Growth Factor
  2. Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro
  3. Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens
  4. Crosstalk between human endogenous retroviruses and exogenous viruses
  5. Bioactive Compounds as Alternative Approaches for Preventing Urinary Tract Infections in the Era of Antibiotic Resistance
  6. HERVs Endophenotype in Autism Spectrum Disorder: Human Endogenous Retroviruses, Specific Immunoreactivity, and Disease Association in Different Family Members
  7. Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection
  8. Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children
  9. Antioxidant Phytocomplexes Extracted from Pomegranate (Punica granatum L.) Using Hydrodynamic Cavitation Show Potential Anticancer Activity In Vitro
  10. Antioxidant Phytocomplexes Isolated from Pomegranate (<em>Punica granatum</em> L.) Using Hydrodynamic Cavitation Reveal Potential Application as Adjuvants in Cancer Therapies
  11. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents
  12. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity
  13. Differential Expression of Endogenous Retroviruses and Inflammatory Mediators in Female and Male Offspring in a Mouse Model of Maternal Immune Activation
  14. Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations
  15. MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia
  16. High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients
  17. High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients
  18. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients
  19. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
  20. Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview
  21. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders
  22. The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs
  23. Human endogenous retroviruses role in cancer cell stemness
  24. The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy
  25. Early Behavioral Alterations and Increased Expression of Endogenous Retroviruses Are Inherited Across Generations in Mice Prenatally Exposed to Valproic Acid
  26. Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy
  27. Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases
  28. High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders
  29. Thymosin alpha 1 and HIV-1: recent advances and future perspectives
  30. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features
  31. The EuroSciCon's 2015 Innate Immunity Summit
  32. Abstract C03: Role of human endogenous retrovirus-K in phenotype-switching of metastatic melanoma cells during microenvironment alterations
  33. Historical review on thymosin α1 in oncology: preclinical and clinical experiences
  34. Thymosin α 1 potentiates the release by CD8+cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infectionin vitro
  35. Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB
  36. Transcriptional Activity of Human Endogenous Retroviruses in Human Peripheral Blood Mononuclear Cells
  37. Detection of high levels of S urvivin–immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis
  38. Human endogenous retroviruses and ADHD
  39. HERVs Expression in Autism Spectrum Disorders
  40. Thymosin α1 and cancer: action on immune effector and tumor target cells
  41. Retrotransposon-Encoded Reverse Transcriptase in the Genesis, Progression and Cellular Plasticity of Human Cancer
  42. Inhibition of NF-κB activation sensitizes U937 cells to 3′-azido-3′-deoxythymidine induced apoptosis
  43. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1
  44. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation
  45. Effector caspase activation, in the absence of a conspicuous apoptosis induction, in mononuclear cells treated with azidothymidine
  46. Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis
  47. Effect of Phosphonated Carbocyclic 2′-Oxa-3′-Aza-Nucleoside on Human T-Cell Leukemia Virus Type 1 Infection In Vitro
  48. Thymosin Alpha 1: From Bench to Bedside
  49. Apoptotic Cell Signaling in Lymphocytes from HIV+ Patients during Successful Therapy
  50. Activation of human endogenous retrovirus-K and production of infectious viral-like particles in human melanoma cells
  51. Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy
  52. Modulation of apoptosis during HTLV-1-mediated immortalization process in vitro
  53. Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer
  54. Effect of Lamivudine on Transmission of Human T-Cell Lymphotropic Virus Type 1 to Adult Peripheral Blood Mononuclear Cells In Vitro
  55. Defective Fas ligand production in lymphocytes from MS patients
  56. Efficacy of 3′-azido 3′deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells
  57. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro
  58. Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression
  59. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
  60. Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry
  61. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I.
  62. Immunological and endocrinological disturbances in patients after prolonged coma following head injury
  63. Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures.
  64. Immunological Events during the Early Phase of Infection with Schistosoma Mansoni in Mice